Target intelligence / Profile preview

Tight junction protein ZO-2 (ZO-2)

Target
ZO-2
Molecular classification
Scaffold/adaptor protein, Membrane-associated guanylate kinase (MAGUK) family, Tight junction-associated protein
01

Overview

Tight junction protein ZO-2 (ZO-2, encoded by TJP2) is a membrane-associated scaffold protein in the tight junction multiprotein complex, crucial for assembling and regulating tight junctions in epithelial and endothelial tissues[2][3][4]. It binds transmembrane proteins and cytoskeletal elements, maintaining the paracellular barrier and cell polarity. ZO-2 is implicated in cellular signaling, gene expression, apoptosis, cell proliferation, and cytoskeletal organization. Pathogenic variants in TJP2 cause progressive familial intrahepatic cholestasis type 4, a rare but severe pediatric liver disease. Disruption of its function leads to loss of barrier integrity, altered gene regulation, and increased cell death[2][3][4].

Other names
TJP2ZO-2Zona occludens 2
02

Mechanism of action

Not applicable (no direct-TJP2 drug described)

03

Biological functions

Scaffold for tight junction assemblyMaintenance of epithelial and endothelial barrier functionRegulation of gene expression (nuclear interactions)Cell proliferation regulationApoptosis induction (upon knockdown)Cytoskeletal organization (actin/microfilament interactions)
04

Disease associations

Cholestatic liver diseases, especially PFIC type 4 (Progressive familial intrahepatic cholestasis type 4)Other epithelial barrier disorders (potential, by analogy to other tight junction defects)
05

Safety considerations

Loss-of-function mutations disrupt tight junction barrier, leading to cholestasis and potentially severe liver diseaseKnockdown results in impaired cell proliferation and increased apoptosis
06

Biomarkers

Pathogenic TJP2 gene variants (e.g., c.1202A>G, c.2668-11A>G) are used as genetic biomarkers for PFIC type 4 and patient selection

Beyond the preview

Go deeper on Tight junction protein ZO-2 (ZO-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tight junction protein ZO-2 (ZO-2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call